Cancer-Focused Biopharma Co. Tallies $60M Funding Round
By Matthew Guarnaccia ( December 21, 2017, 4:30 PM EST) -- Biopharmaceutical firm FLX Bio Inc. on Thursday said its latest funding round brought in $60 million from new and existing investors that will help the company advance a leading treatment through clinical trials and push forward with other drug candidate programs....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.